Accession | Title | Sample type | Organism(s) | Ch | Platform | Series | Supplementary | Contact | Release date |
---|---|---|---|---|---|---|---|---|---|
![]() |
![]() |
||||||||
GSM8788612 |
ATAC-seq WT PGCLC aggregates, no cytokines, day 2, rep1
|
SRA | 1 | Elisa Barbieri | Feb 17, 2025 | ||||
GSM8788613 |
ATAC-seq WT PGCLC aggregates, no cytokines, day 2, rep2
|
SRA | 1 | Elisa Barbieri | Feb 17, 2025 | ||||
GSM8788614 |
ATAC-seq Otx2-/- 2i/LIF ESCs rep1
|
SRA | 1 | Elisa Barbieri | Feb 17, 2025 | ||||
GSM8788615 |
ATAC-seq Otx2-/- 2i/LIF ESCs rep2
|
SRA | 1 | Elisa Barbieri | Feb 17, 2025 | ||||
GSM8788616 |
ATAC-seq Otx2-/- EpiLCs rep1
|
SRA | 1 | Elisa Barbieri | Feb 17, 2025 | ||||
GSM8788617 |
ATAC-seq Otx2-/- EpiLCs rep2
|
SRA | 1 | Elisa Barbieri | Feb 17, 2025 | ||||
GSM8788618 |
ATAC-seq Otx2-/- PGCLC aggregates, plus cytokines, day 2 rep1
|
SRA | 1 | Elisa Barbieri | Feb 17, 2025 | ||||
GSM8788619 |
ATAC-seq Otx2-/- PGCLC aggregates, plus cytokines, day 2 rep2
|
SRA | 1 | Elisa Barbieri | Feb 17, 2025 | ||||
GSM8788620 |
ATAC-seq Otx2-/- OTX2-ERT2 EpiLCs, untreated, rep1
|
SRA | 1 | Elisa Barbieri | Feb 17, 2025 | ||||
GSM8788621 |
ATAC-seq Otx2-/- OTX2-ERT2 EpiLCs, Tamoxifen 1h, rep1
|
SRA | 1 | Elisa Barbieri | Feb 17, 2025 | ||||
GSM8788622 |
ATAC-seq Otx2-/- OTX2-ERT2 EpiLCs, Tamoxifen 6h, rep1
|
SRA | 1 | Elisa Barbieri | Feb 17, 2025 | ||||
GSM8788623 |
ATAC-seq Otx2-/- OTX2-ERT2 EpiLCs, untreated, rep2
|
SRA | 1 | Elisa Barbieri | Feb 17, 2025 | ||||
GSM8788624 |
ATAC-seq Otx2-/- OTX2-ERT2 EpiLCs, Tamoxifen 1h, rep2
|
SRA | 1 | Elisa Barbieri | Feb 17, 2025 | ||||
GSM8788625 |
ATAC-seq Otx2-/- OTX2-ERT2 EpiLCs, Tamoxifen 6h, rep2
|
SRA | 1 | Elisa Barbieri | Feb 17, 2025 | ||||
GSM8788626 |
ATAC-seq Otx2-/- OTX2-ERT2 PGCLC aggregates, plus cytokines, day 2, untreated, rep1
|
SRA | 1 | Elisa Barbieri | Feb 17, 2025 | ||||
GSM8788627 |
ATAC-seq Otx2-/- OTX2-ERT2 PGCLC aggregates, plus cytokines, day 2, untreated, rep2
|
SRA | 1 | Elisa Barbieri | Feb 17, 2025 | ||||
GSM8788628 |
ATAC-seq Otx2-/- OTX2-ERT2 PGCLC aggregates, plus cytokines, day 2, Tamoxifen d0-d2, rep1
|
SRA | 1 | Elisa Barbieri | Feb 17, 2025 | ||||
GSM8788629 |
ATAC-seq Otx2-/- OTX2-ERT2 PGCLC aggregates, plus cytokines, day 2, Tamoxifen d0-d2, rep2
|
SRA | 1 | Elisa Barbieri | Feb 17, 2025 | ||||
GSM8788630 |
ATAC-seq Otx2-/- OTX2-ERT2 PGCLC aggregates, plus cytokines, day 4, untreated, rep1
|
SRA | 1 | Elisa Barbieri | Feb 17, 2025 | ||||
GSM8788631 |
ATAC-seq Otx2-/- OTX2-ERT2 PGCLC aggregates, plus cytokines, day 4, untreated, rep2
|
SRA | 1 | Elisa Barbieri | Feb 17, 2025 |